Triple‐negative breast cancer (TNBC), which is characterised by the absence of oestrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2), causes the highest risk of recurrence and the worst prognosis among all breast cancer subtypes [4, 5]. This evidence concerns the gene PGR and breast carcinoma.